(Q36404504)

14 August 2017

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes (English)

1 reference

14 August 2017

0 references

20

Henrik Zetterberg

1 reference

14 August 2017

Ross W Paterson

2

0 references

Ninon Burgos

Ninon Burgos

4

0 references

Anna Barnes

Anna Barnes

9

0 references

David M. Cash

David M Cash

12

0 references

Jason D. Warren

Jason D Warren

17

0 references

Martin Rossor

Martin N Rossor

18

0 references

Sebastien Ourselin

13

Sebastien Ourselin

1 reference

14 August 2017

15

Michael P Lunn

1 reference

14 August 2017

3

Marc Modat

1 reference

14 August 2017

Philip S J Weston

1

1 reference

14 August 2017

Manuel J Cardoso

5

1 reference

14 August 2017

Nadia Magdalinou

6

1 reference

14 August 2017

Manja Lehmann

7

1 reference

14 August 2017

John C Dickson

8

1 reference

14 August 2017

Jamshed B Bomanji

10

1 reference

14 August 2017

Irfan Kayani

11

1 reference

14 August 2017

Jamie Toombs

14

1 reference

14 August 2017

Catherine J Mummery

16

1 reference

14 August 2017

Nick C Fox

19

1 reference

14 August 2017

Jonathan M Schott

21

1 reference

14 August 2017

2 November 2015

1 reference

Alzheimer's & dementia (Amsterdam, Netherlands)

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

4

1 reference

14 August 2017

440-446

1 reference

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

CSF biomarker variability in the Alzheimer's Association quality control program

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Primary progressive aphasia: defining genetic and pathological subtypes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

CSF markers for incipient Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Posterior cortical atrophy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

21 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26835507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Geodesic information flows

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26835507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.DADM.2015.10.001

0 references

1 reference

14 August 2017

PubMed publication ID

26835507

1 reference